PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
PET/CT生物标志物可用于对参与LOTIS-2临床试验的复发/难治性弥漫性大B细胞淋巴瘤患者进行风险分层
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1561
Alderuccio, Juan Pablo; Reis, Isildinha M; Hamadani, Mehdi; Nachiappan, Muthiah; Leslom, Salman; Kahl, Brad S; Ai, Weiyun Z; Radford, John; Solh, Melhem; Ardeshna, Kirit M; Hess, Brian T; Lunning, Matthew A; Zinzani, Pier Luigi; Stathis, Anastasios; Carlo-Stella, Carmelo; Lossos, Izidore S; Caimi, Paolo F; Han, Sunwoo; Yang, Fei; Kuker, Russ A; Moskowitz, Craig H
